See also: HIV and the Immune System; Cell Therapy and HIV; Gene Therapy and HIV; Interleukin-2; and Vaccines to Prevent or Treat HIV Infection
General Information
- Immune Restoration (AIDS InfoNet) and Spanish version
- Immunotherapy (AIDSInfo) and Spanish version
- Passive immunotherapy (AIDSInfo) and Spanish version
- Interleukin-2 (AIDS Infonet) and Spanish version
Selected Recent Articles
- Gilead Signs Deal With Biotech Company to Develop HIV Antibody Treatment. (August 2016, Poz)
- HIV Cure Research Strategies. (July 2016, TheBodyPro)
- Pediatric HIV Cure Studied in Infant Monkeys. (July 2016, TheBodyPro)
- HIV will only be cured with combinations too, conference delegates hear. (July 2016, AIDSmap)
- Immune-Enhancing Treatment May Destabilize HIV Reservoirs. (July 2016, NIH)
- Experimental Therapy Fails to Stop Viral Rebound Post-HIV Treatment Interruption. (July 2016, Poz)
- 2016 HIV Cure Update: Therapeutic Vaccines and Broadly Neutralizing Antibodies. (July 2016, TheBodyPro)
- HIV Antibody 3BNC117 Delays Viral Rebound, Could Be Component of Cure. (June 2016, Poz)
- Weekly PRO 140 Antibody Injections Successfully Combat HIV in Some. (June 2016, Poz); related coverage from AIDSmap
- Weekly PRO 140 Antibody Injections May Work as HIV Maintenance Therapy. (June 2016, TheBodyPro); related coverage from Healio and MedPage Today
- Studies Begin to Test Long-Acting Antibody Infusions for HIV Prevention. (April 2016, Poz); related coverage from NIAID
- Reflection on bNAbs [broadly neutralizing antibodies] and Broadening the Toolbox. (March 2016, AVAC)
- A FRESH Look at Basic HIV Cure Research. (March 2016, AVAC)
- Antibody Injections Clear HIV-Like Virus in Infant Monkeys. (March 2016, Poz)
- Dose-finding trials of antibody-based drugs for HIV prevention will start soon. (February 2016, AIDSmap)
- Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption. (February 2016, AIDSmap)
- Supercharging NK cells for cure. (February 2016, Retrovirus Conference)
- Reducing HIV Viral Reservoirs with Immune-Based Therapy. (January 2016, amfAR)
- Toward an AIDS-Free Generation: Can Antibodies Help? (January 2016, NIH Director’s Blog)
- Antibody Infusion Successfully Combats HIV in Early Trial. (January 2016, Poz)
- Widely-used anti-alcoholism drug wakes up dormant HIV-infected cells. (November 2015, AIDSmap)
- A Tale of Two Diagnoses. (November 2015, Poz)
- HIV Cure Search Sees New Protein Work on Latently Infected Cells. (October 2015, Poz)
- Gene Therapy Controls HIV Longer Than Four Months in Study. (September 2015, Poz)
- On the Cure Front, More Drugs Appear to Spur Latent HIV. (September 2015, Poz)
- Discovering an Antibody With Refined Abilities to Combat HIV. (September 2015, Poz)
- New drug holds out promise of long-term control or even cure of HIV. (July 2015, AIDSmap)
- Keeping Latent HIV Dormant May Lead to Functional Cure. (July 2015, Poz)
- NIH awards $7.5 million to Penn Medicine for HIV gene therapy. (May 2015, Healio)
- HIV Vaccine Boosts Effects of Antiretrovirals. (May 2015, Poz)
- Blocking PD-1: Progress in HIV Cure Research. (April 2015, Beta Blog)
- HIV Antibody Infusion Shows Promise in Treating The Virus. (April 2015, Poz)
- Compound Found to Block HIV Receptors in Monkeys. (April 2015, Beta Blog)
- Gilead Drug Shows Promise in Reversing HIV Latency. (March 2015, Poz)
- Experimental agents reverse HIV latency and help immune system fight HIV-infected cells. (March 2015, AIDSmap)
- Shock & Kill: Progress in HIV Cure Research. (March 2015, Beta Blog)
- Immune Cells Can Be Manipulated to Kill HIV-Infected Reservoir Cells. (January 2015, Poz)
- Challenges to Stem Cell Transplantation in HIV-Positive Patients. (October 2014, TheBody)
- Stemming the Flow From HIV Reservoirs With Neutralizing Antibodies. (September 2014, Treatment Action Group)
- Latent HIV Reservoirs Appear to Be Reactivated by Compound Found in Plant. (August 2014, Treatment Action Group)
- Drugs That Target HIV Reservoirs May Also Impair Killer T Cells. (August 2014, TheBodyPro)
- Drug Spurs Latently Infected Cells But Doesn’t Taper HIV Reservoir. (July 2014, Poz)
- Novel techniques probed in cure research. (July 2014, AIDSmap)
- Setbacks and Progress in the Search for an HIV Cure. (July 2014, Beta Blog)
- 2 Australian Men “Cleared” of HIV After Bone Marrow Transplants. (July 2014, TheBodyPro)
- The HDAC inhibitor romidepsin is safe and effectively reverses HIV-1 latency in vivo as measured by standard clinical assays. (July 2014, NATAP)
- Romidepsin activates latent HIV, but does not decrease viral reservoir. (July 2014, AIDSmap)
- Jetsons-Era HIV Care and Prevention. (April 2014, Poz)
- Failure to Awaken Dormant Cells Deals Blow to HIV Cure Research. (March 2014, Poz)
- HIV Rebounds Detailed in Two Boston Stem Cell Transplant Patients. (March 2014, NATAP)
- Culture Shock: The Boston HIV Mystery. (March 2014, MedPage Today)
- The ‘Boston patients’ experience HIV rebound after stem cell transplants. (March 2014, AIDSmap)
- Genetic HIV Therapy Aided by Drug to Boost CD4 Infusion. (March 2014, Poz)
- Genetically Modifying Cells to Resist HIV Shows Promise. (March 2014, Poz)
- A cure may need multiple components, workshop delegates hear. (March 2014, AIDSmap)
- HIV-Specific Poison May Complement ARVs. (January 2014, Poz)
- HIV Resurgence in “Boston Patients” Frustrates, Informs Research Into Cure. (December 2013, Kaiser Family Foundation)
- Dashing Hopes, HIV Rebounds in 2 Men Once Potentially Cured. (December 2013, Poz)
- CD4 gene therapy may enable functional HIV control during treatment interruption. (September 2013, AIDSmap)
- Targeting Reactivated HIV Using Natural Killer Cells: Another Potential Cure Strategy. (September 2013, TheBodyPro)
- Boy With HIV and Leukemia Dies After Cord Blood Transplant. (July 2013, Poz)
- HIV’s Power Harnessed for Good in New Gene Therapies. (July 2013, Poz)
- Two stem cell transplant recipients now controlling HIV off treatment. (July 2013, AIDSmap)